SLC44A1 and COVID-19: S1 + S2 HCoV-OC43 IgG was 4.3-fold higher in the COVID-19 group than in the Ctl1-2018 group (p = 0.002, Figure 2C), but S1 + S2 HCoV-229E IgG did not differ (Figure 2F).